High 18F-FDG Avidity of Low-Grade Esthesioneuroblastoma

Arnaud Jannin, Anthony Turpin, Clio Baillet, Sébastien Aubert, Christine Do Cao

Open source

DOI
10.1097/rlu.0000000000001962
Published
2018-03
Container
Clinical Nuclear Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/rlu.0000000000001962,
  title = {High 18F-FDG Avidity of Low-Grade Esthesioneuroblastoma},
  author = {Arnaud Jannin and Anthony Turpin and Clio Baillet and Sébastien Aubert and Christine Do Cao},
  year = {2018},
  journal = {Clinical Nuclear Medicine},
  doi = {10.1097/rlu.0000000000001962},
  url = {https://doi.org/10.1097/rlu.0000000000001962}
}

RIS

TY  - JOUR
TI  - High 18F-FDG Avidity of Low-Grade Esthesioneuroblastoma
AU  - Arnaud Jannin
AU  - Anthony Turpin
AU  - Clio Baillet
AU  - Sébastien Aubert
AU  - Christine Do Cao
PY  - 2018
JO  - Clinical Nuclear Medicine
DO  - 10.1097/rlu.0000000000001962
UR  - https://doi.org/10.1097/rlu.0000000000001962
ER  - 

APA

Jannin, A., Turpin, A., Baillet, C., Aubert, S., & Cao, C. D. (2018). High 18F-FDG Avidity of Low-Grade Esthesioneuroblastoma. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0000000000001962

Source records